The Company intends for the reverse stock split to become effective and to begin trading on a split-adjusted basis on the OTCQB at the open of trading on September 26, 2025, under the existing trading ...

Essilor Stellest is the first and only FDA market authorized spectacle lens in the United States EssilorLuxottica’s lens is clinically proven to slow myopia progression in children1,2 ...

In order to participate, please register in advance here to obtain a local or toll-free phone number and your personal pin. A live webcast of the call will be available on Teva's website at: ...

■About World ID World ID is a global authentication technology that proves “humanness.” In recent years, with the rapid evolution of generative AI, we are entering a society where it is difficult to ...

Investors can register for the conference by contacting their ROTH Capital Partners representative. About LifeMD, Inc.

TEL AVIV, Israel, Sept. 25, 2025 (GLOBE NEWSWIRE) -- Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) announced today that its Q3 2025 Aide Memoire is available on the “Investors” page on its ...

The complaint specifically alleges infringement on three key patents, including U.S. Patent No. 10,463,520, U.S. Patent No. 11,779,482, and U.S. Patent No. 11,974,934, and Medtimo stands fully ...

PALSONIFY™ (paltusotine) INDICATION: PALSONIFY is a somatostatin receptor agonist indicated for the treatment of adults with acromegaly who had an inadequate response to surgery and/or for whom ...

NASHVILLE, Tenn., Sept. 25, 2025 (GLOBE NEWSWIRE) -- Harrow (Nasdaq: HROW), a leading provider of ophthalmic disease management solutions in North America, today announced the launch of Harrow Access ...

When it comes to the best pill for enhancing a woman's sex life, the answer is simple: Oh Yes. This American-made supplement is packed with some of the most effective, all-natural libido-boosting ...

The fully enrolled 594 patient second Phase 3 trial is a prospective, double-blind, multicenter, saline-controlled, parallel group, RCT of ReNu ASA, for the treatment of subjects with mild to severe ...

Questions may be submitted (via chat function) during the live webinar or submitted in advance via email to investors@xenon-pharma.com. A live webcast of the webinar will be available on the “ ...